Open Access<p>Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study</p>
Author(s) -
Hongqing Zhuang,
Hongqin Zhuang,
Siyu Shi,
Yuxia Wang
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s223258
Subject(s) - medicine , bevacizumab , adverse effect , edema , cerebral edema , necrosis , radiation therapy , chemotherapy
To investigate the treatment efficacy of ultra-low-dose bevacizumab for cerebral radiation necrosis.